Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP450163.RABas_t5wlMnNzVdcsOZ63LlKgr45_dFf7w-MRXU48Y0E130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP450163.RABas_t5wlMnNzVdcsOZ63LlKgr45_dFf7w-MRXU48Y0E130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP450163.RABas_t5wlMnNzVdcsOZ63LlKgr45_dFf7w-MRXU48Y0E130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP450163.RABas_t5wlMnNzVdcsOZ63LlKgr45_dFf7w-MRXU48Y0E130_provenance.
- NP450163.RABas_t5wlMnNzVdcsOZ63LlKgr45_dFf7w-MRXU48Y0E130_assertion description "[We show that pharmacological inhibition of CD38 results in higher intracellular NAD(+) levels and that treatment of cell cultures with apigenin decreases global acetylation as well as the acetylation of p53 and RelA-p65.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP450163.RABas_t5wlMnNzVdcsOZ63LlKgr45_dFf7w-MRXU48Y0E130_provenance.
- NP450163.RABas_t5wlMnNzVdcsOZ63LlKgr45_dFf7w-MRXU48Y0E130_assertion evidence source_evidence_literature NP450163.RABas_t5wlMnNzVdcsOZ63LlKgr45_dFf7w-MRXU48Y0E130_provenance.
- NP450163.RABas_t5wlMnNzVdcsOZ63LlKgr45_dFf7w-MRXU48Y0E130_assertion SIO_000772 23172919 NP450163.RABas_t5wlMnNzVdcsOZ63LlKgr45_dFf7w-MRXU48Y0E130_provenance.
- NP450163.RABas_t5wlMnNzVdcsOZ63LlKgr45_dFf7w-MRXU48Y0E130_assertion wasDerivedFrom befree-20140225 NP450163.RABas_t5wlMnNzVdcsOZ63LlKgr45_dFf7w-MRXU48Y0E130_provenance.
- NP450163.RABas_t5wlMnNzVdcsOZ63LlKgr45_dFf7w-MRXU48Y0E130_assertion wasGeneratedBy ECO_0000203 NP450163.RABas_t5wlMnNzVdcsOZ63LlKgr45_dFf7w-MRXU48Y0E130_provenance.
- befree-20140225 importedOn "2014-02-25" NP450163.RABas_t5wlMnNzVdcsOZ63LlKgr45_dFf7w-MRXU48Y0E130_provenance.